Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
4(20%)
Results Posted
17%(1 trials)
Terminated
1(5%)

Phase Distribution

Ph phase_1
11
55%
Ph phase_2
4
20%
Ph early_phase_1
1
5%
Ph not_applicable
4
20%

Phase Distribution

12

Early Stage

4

Mid Stage

0

Late Stage

Phase Distribution20 total trials
Early Phase 1First-in-human
1(5.0%)
Phase 1Safety & dosage
11(55.0%)
Phase 2Efficacy & side effects
4(20.0%)
N/ANon-phased studies
4(20.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

4

trials recruiting

Total Trials

20

all time

Status Distribution
Active(5)
Completed(6)
Terminated(1)
Other(8)

Detailed Status

unknown8
Completed6
Recruiting3
Active, not recruiting1
Terminated1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
20
Active
4
Success Rate
85.7%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (5.0%)
Phase 111 (55.0%)
Phase 24 (20.0%)
N/A4 (20.0%)

Trials by Status

active_not_recruiting15%
recruiting315%
terminated15%
unknown840%
completed630%
not_yet_recruiting15%

Recent Activity

Clinical Trials (20)

Showing 20 of 20 trials
NCT05697718Phase 1

Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cells (IxCell hUC-MSC-S) in the Treatment of Ischemic Stroke

Completed
NCT05820711Phase 1

Study Transplanting Bone Marrow Cells Into Salivary Glands to Treat Dry Mouth Caused by Radiation Therapy

Active Not Recruiting
NCT06823063Phase 1

Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cells (IxCell hUC-MSC-P) in the Treatment of CTD-ILD

Not Yet Recruiting
NCT06813157Not Applicable

Mesenchymal Stem Cells in the Treatment of Refractory Primary Immune Thrombocytopenia

Recruiting
NCT06805448Phase 1

Intraglandular Treatment With Adipose-derived Mesenchymal Stem Cells in Patients With Xerostomia Due to Sjögren's Disease

Recruiting
NCT06788470Phase 1

Safety and Efficacy of Umbilical Cord-derived Mesenchymal Stem Cell(MSC) Transplantation in the Treatment of Bronchopulmonary Dysplasia(BPD) in Premature Infants

Recruiting
NCT01175655Phase 1

A Study to Evaluate the Potential of Mesenchymal Stromal Cells to Treat Obliterative Bronchiolitis After Lung Transplantation

Completed
NCT04377334Phase 2

Mesenchymal Stem Cells (MSCs) in Inflammation-Resolution Programs of Coronavirus Disease 2019 (COVID-19) Induced Acute Respiratory Distress Syndrome (ARDS)

Unknown
NCT03371329Phase 1

Mesenchymal Stem Cells Therapy in Patients With Recent Intracerebral Hemorrhage

Completed
NCT04611256Phase 1

Mesenchymal Stem Cells in Patients Diagnosed With COVID-19

Unknown
NCT03386422Not Applicable

Mindfulness Self-Compassion Intervention Versus a Cognitive-Behavioral Intervention to Improve Self-care in Chronic Pain

Completed
NCT03552848Not Applicable

Mesenchymal Stem Cells for Multiple Organ Dysfuntion Syndrome After Surgical Repaire of Acute Type A Aortic Dissection

Unknown
NCT02379442Phase 1

Early Treatment of Acute Graft Versus Host Disease With Bone Marrow-Derived Mesenchymal Stem Cells and Corticosteroids

Terminated
NCT03795974Phase 2

Efficacy of Allogeneic Umbilical Cord Derived Hematopoietic and Mesenchymal Stem Cells in Cerebral Palsy

Unknown
NCT03564808Phase 2

Long Term Effects on Skin Hyper Pigmentation With and Without Mesenchymal Stem Cell Enriched Adipose Tissue Grafting for "Contour Deformities With Pigmentary Changes on Face"

Unknown
NCT03460223Phase 1

Safety and Efficacy Study of Mesenchymal Stem Cell in Treating Kidney Fibrosis

Unknown
NCT01709656Not Applicable

A Molecule Basic Study of Early Warning for New Pathogenic Risk of Ankylosing Spondylitis

Completed
NCT02307435Early Phase 1

Allogenic Mesenchymal Stem Cell for Bone Defect or Non Union Fracture

Unknown
NCT01449032Phase 2

MesenchYmal STROMAL CELL Therapy in Patients With Chronic Myocardial Ischemia (MyStromalCell Trial)

Completed
NCT01413035Phase 1

Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Type 2 Diabetes

Unknown

All 20 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
20